Cimosir Rivaroxaban correction liquid and quality control liquid - Taiwan Registration 9d34049d7c583ccd426393b116c0da47
Access comprehensive regulatory information for Cimosir Rivaroxaban correction liquid and quality control liquid in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9d34049d7c583ccd426393b116c0da47 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is suitable for calibration and quality control when measuring Rivaroxaban in the Liquid Anti-Xa test of ACL TOP Family.
A Clinical chemistry and clinical toxicology
A.1150 calibration;; A.1660 Quality control materials (analytical and non-analytical)
import
Dates and Status
May 16, 2018
May 16, 2028

